Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gadobutrol

2

II.a Pulmonary edema, noncardiogenic (NCPE)

1
Last update : 13/12/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Gadolinium-based MRI contrast media
2

Publications

Acute respiratory distress syndrome after the use of gadolinium contrast agent.
Respiratory medicine case reports 2018;25;336-338 2018
Severe Acute Cardiopulmonary Failure Related to Gadobutrol Magnetic Resonance Imaging Contrast Reaction: Successful Resuscitation With Extracorporeal Membrane Oxygenation.
Mayo Clinic proceedings 2016 Mar;91;362-6 2016 Mar
Acute Respiratory Distress Syndrome after the Use of Gadolinium Contrast Media.
Yonsei medical journal 2015 Jul;56;1155-7 2015 Jul
Magnetic resonance imaging contrast agent related pulmonary edema: a case report.
European review for medical and pharmacological sciences 2012 Oct;16 Suppl 4;110-2 2012 Oct

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies